• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.620 -0.170 (-9.50%)
Official Closing Price Updated: 8:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,666
Open 1.790
Bid (Size) 1.550 (200)
Ask (Size) 1.800 (100)
Prev. Close 1.790
Today's Range 1.570 - 1.790
52wk Range 1.493 - 98.72
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients
August 06, 2026
Via Investor Brand Network
Existing Immune Protein May Boost Immunotherapy Against Cancer
August 05, 2026
Via Investor Brand Network

Performance

YTD
-91.4%
-91.4%
1 Month
-28.7%
-28.7%
3 Month
-51.9%
-51.9%
6 Month
-88.3%
-88.3%
1 Year
-98.2%
-98.2%

More News

Read More
Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response
July 28, 2026
Via Investor Brand Network
Dietary Fat Balance Could Influence Immune System Function, Study Finds
July 22, 2026
Via Investor Brand Network
Wondering what's happening in today's pre-market session? ↗
July 21, 2026
Via Chartmill
Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy
June 17, 2026
Via Investor Brand Network
Top movers in Monday's after hours session ↗
July 20, 2026
Via Chartmill
Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
July 17, 2026
Via Investor Brand Network
Understanding Why Treatment Resistance Exists in Many Cancers
July 09, 2026
Via Investor Brand Network
AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer
July 08, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy
July 02, 2026
Via Investor Brand Network
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
June 30, 2026
Via Investor Brand Network
Why Men Need Sexual Health Help While Undergoing Cancer Treatment
June 22, 2026
Via Investor Brand Network
FIU Researchers Discover New Way of Extending Immune Cell Lifespan and Effectiveness
June 11, 2026
Via Investor Brand Network
News headline image
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
June 05, 2026
Via ACCESS Newswire
New Pill Offers Hope Against Pancreatic Cancer
June 03, 2026
Via Investor Brand Network
New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer
June 02, 2026
Via Investor Brand Network
Scientists Inch Closer to Developing a Lung Cancer Blood Test
May 21, 2026
Via Investor Brand Network
Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer
May 20, 2026
Via Investor Brand Network
NHS Starts Offering Immunotherapy Injection to Cancer Patients
May 12, 2026
Via Investor Brand Network
Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes
May 11, 2026
Via Investor Brand Network
Study Finds That Vitamin D Supercharges Chemotherapy Against Breast Cancer
May 04, 2026
Via Investor Brand Network
Study Uncovers Why the Risk of Breast Cancer Increases with Age
May 01, 2026
Via Investor Brand Network
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
April 30, 2026
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
April 29, 2026
Via Chartmill

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 1.620
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 08/07/26 08:00 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 11.61M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap